AP1B plays an important role in intestinal tumorigenesis with the truncating mutation of an APC gene

Mitsuko Mimura, Atsuhiro Masuda, Shin Nishiumi, Kazuyuki Kawakami, Yoshimi Fujishima, Tomoo Yoshie, Shigeto Mizuno, Ikuya Miki, Hiroshi Ohno, Kouji Hase, Toshinari Minamoto, Takeshi Azuma, Masaru Yoshida

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Recent evidence has suggested that carcinoma is accompanied by the loss of cell polarity. An epithelial cell-specific form of the AP-1 clathrin adaptor complex, AP1B, is involved in the polarized transport of membrane proteins to the basolateral surface of epithelial cells. In our study, we investigated whether AP1B is involved in intestinal tumorigenesis. The cellular polarity of intestinal tumor cells was examined using APC Min/+ mice as an in vivo model and SW480 cells with a truncating mutation in the adenomatous polyposis coli (APC) gene as an in vitro model by confocal microscopy. Next, the expression of AP1B in intestinal tumor cells was examined by real-time polymerase chain reaction (PCR) and Western blotting. The localization of β-catenin and the expression of AP1B in the tumor tissue of patients with colorectal cancer were evaluated by confocal microscopy and real-time PCR, respectively, and the relationships among cell polarity, AP1B expression and intestinal tumorigenesis were examined. Cellular polarity was lost in intestinal tumor cells, and the expression of AP1B was downregulated. In addition, the reduction in the expression level of AP1B correlated with the nuclear localization of β-catenin in human colorectal cancer. Our study indicates the close associations between AP1B, intestinal tumorigenesis and mutations in the APC gene. This is the first report to reveal the relationships among AP1B, cellular polarity and intestinal tumorigenesis, and achieving a detailed understanding of AP1B will hopefully lead to discovery of therapeutic targets and novel biomarkers for intestinal cancer.

Original languageEnglish
Pages (from-to)1011-1020
Number of pages10
JournalInternational Journal of Cancer
Volume130
Issue number5
DOIs
Publication statusPublished - 2012 Mar 1
Externally publishedYes

Fingerprint

APC Genes
Carcinogenesis
Catenins
Cell Polarity
Mutation
Confocal Microscopy
Real-Time Polymerase Chain Reaction
Colorectal Neoplasms
Neoplasms
Epithelial Cells
Vesicular Transport Adaptor Proteins
Intestinal Neoplasms
Adenomatous Polyposis Coli
Membrane Transport Proteins
Transcription Factor AP-1
Down-Regulation
Biomarkers
Western Blotting
Carcinoma

Keywords

  • AP1B
  • APC
  • intestine
  • polarity
  • tumorigenesis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mimura, M., Masuda, A., Nishiumi, S., Kawakami, K., Fujishima, Y., Yoshie, T., ... Yoshida, M. (2012). AP1B plays an important role in intestinal tumorigenesis with the truncating mutation of an APC gene. International Journal of Cancer, 130(5), 1011-1020. https://doi.org/10.1002/ijc.26131

AP1B plays an important role in intestinal tumorigenesis with the truncating mutation of an APC gene. / Mimura, Mitsuko; Masuda, Atsuhiro; Nishiumi, Shin; Kawakami, Kazuyuki; Fujishima, Yoshimi; Yoshie, Tomoo; Mizuno, Shigeto; Miki, Ikuya; Ohno, Hiroshi; Hase, Kouji; Minamoto, Toshinari; Azuma, Takeshi; Yoshida, Masaru.

In: International Journal of Cancer, Vol. 130, No. 5, 01.03.2012, p. 1011-1020.

Research output: Contribution to journalArticle

Mimura, M, Masuda, A, Nishiumi, S, Kawakami, K, Fujishima, Y, Yoshie, T, Mizuno, S, Miki, I, Ohno, H, Hase, K, Minamoto, T, Azuma, T & Yoshida, M 2012, 'AP1B plays an important role in intestinal tumorigenesis with the truncating mutation of an APC gene', International Journal of Cancer, vol. 130, no. 5, pp. 1011-1020. https://doi.org/10.1002/ijc.26131
Mimura, Mitsuko ; Masuda, Atsuhiro ; Nishiumi, Shin ; Kawakami, Kazuyuki ; Fujishima, Yoshimi ; Yoshie, Tomoo ; Mizuno, Shigeto ; Miki, Ikuya ; Ohno, Hiroshi ; Hase, Kouji ; Minamoto, Toshinari ; Azuma, Takeshi ; Yoshida, Masaru. / AP1B plays an important role in intestinal tumorigenesis with the truncating mutation of an APC gene. In: International Journal of Cancer. 2012 ; Vol. 130, No. 5. pp. 1011-1020.
@article{9360d129241c42a985c21e5e759e143f,
title = "AP1B plays an important role in intestinal tumorigenesis with the truncating mutation of an APC gene",
abstract = "Recent evidence has suggested that carcinoma is accompanied by the loss of cell polarity. An epithelial cell-specific form of the AP-1 clathrin adaptor complex, AP1B, is involved in the polarized transport of membrane proteins to the basolateral surface of epithelial cells. In our study, we investigated whether AP1B is involved in intestinal tumorigenesis. The cellular polarity of intestinal tumor cells was examined using APC Min/+ mice as an in vivo model and SW480 cells with a truncating mutation in the adenomatous polyposis coli (APC) gene as an in vitro model by confocal microscopy. Next, the expression of AP1B in intestinal tumor cells was examined by real-time polymerase chain reaction (PCR) and Western blotting. The localization of β-catenin and the expression of AP1B in the tumor tissue of patients with colorectal cancer were evaluated by confocal microscopy and real-time PCR, respectively, and the relationships among cell polarity, AP1B expression and intestinal tumorigenesis were examined. Cellular polarity was lost in intestinal tumor cells, and the expression of AP1B was downregulated. In addition, the reduction in the expression level of AP1B correlated with the nuclear localization of β-catenin in human colorectal cancer. Our study indicates the close associations between AP1B, intestinal tumorigenesis and mutations in the APC gene. This is the first report to reveal the relationships among AP1B, cellular polarity and intestinal tumorigenesis, and achieving a detailed understanding of AP1B will hopefully lead to discovery of therapeutic targets and novel biomarkers for intestinal cancer.",
keywords = "AP1B, APC, intestine, polarity, tumorigenesis",
author = "Mitsuko Mimura and Atsuhiro Masuda and Shin Nishiumi and Kazuyuki Kawakami and Yoshimi Fujishima and Tomoo Yoshie and Shigeto Mizuno and Ikuya Miki and Hiroshi Ohno and Kouji Hase and Toshinari Minamoto and Takeshi Azuma and Masaru Yoshida",
year = "2012",
month = "3",
day = "1",
doi = "10.1002/ijc.26131",
language = "English",
volume = "130",
pages = "1011--1020",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - AP1B plays an important role in intestinal tumorigenesis with the truncating mutation of an APC gene

AU - Mimura, Mitsuko

AU - Masuda, Atsuhiro

AU - Nishiumi, Shin

AU - Kawakami, Kazuyuki

AU - Fujishima, Yoshimi

AU - Yoshie, Tomoo

AU - Mizuno, Shigeto

AU - Miki, Ikuya

AU - Ohno, Hiroshi

AU - Hase, Kouji

AU - Minamoto, Toshinari

AU - Azuma, Takeshi

AU - Yoshida, Masaru

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Recent evidence has suggested that carcinoma is accompanied by the loss of cell polarity. An epithelial cell-specific form of the AP-1 clathrin adaptor complex, AP1B, is involved in the polarized transport of membrane proteins to the basolateral surface of epithelial cells. In our study, we investigated whether AP1B is involved in intestinal tumorigenesis. The cellular polarity of intestinal tumor cells was examined using APC Min/+ mice as an in vivo model and SW480 cells with a truncating mutation in the adenomatous polyposis coli (APC) gene as an in vitro model by confocal microscopy. Next, the expression of AP1B in intestinal tumor cells was examined by real-time polymerase chain reaction (PCR) and Western blotting. The localization of β-catenin and the expression of AP1B in the tumor tissue of patients with colorectal cancer were evaluated by confocal microscopy and real-time PCR, respectively, and the relationships among cell polarity, AP1B expression and intestinal tumorigenesis were examined. Cellular polarity was lost in intestinal tumor cells, and the expression of AP1B was downregulated. In addition, the reduction in the expression level of AP1B correlated with the nuclear localization of β-catenin in human colorectal cancer. Our study indicates the close associations between AP1B, intestinal tumorigenesis and mutations in the APC gene. This is the first report to reveal the relationships among AP1B, cellular polarity and intestinal tumorigenesis, and achieving a detailed understanding of AP1B will hopefully lead to discovery of therapeutic targets and novel biomarkers for intestinal cancer.

AB - Recent evidence has suggested that carcinoma is accompanied by the loss of cell polarity. An epithelial cell-specific form of the AP-1 clathrin adaptor complex, AP1B, is involved in the polarized transport of membrane proteins to the basolateral surface of epithelial cells. In our study, we investigated whether AP1B is involved in intestinal tumorigenesis. The cellular polarity of intestinal tumor cells was examined using APC Min/+ mice as an in vivo model and SW480 cells with a truncating mutation in the adenomatous polyposis coli (APC) gene as an in vitro model by confocal microscopy. Next, the expression of AP1B in intestinal tumor cells was examined by real-time polymerase chain reaction (PCR) and Western blotting. The localization of β-catenin and the expression of AP1B in the tumor tissue of patients with colorectal cancer were evaluated by confocal microscopy and real-time PCR, respectively, and the relationships among cell polarity, AP1B expression and intestinal tumorigenesis were examined. Cellular polarity was lost in intestinal tumor cells, and the expression of AP1B was downregulated. In addition, the reduction in the expression level of AP1B correlated with the nuclear localization of β-catenin in human colorectal cancer. Our study indicates the close associations between AP1B, intestinal tumorigenesis and mutations in the APC gene. This is the first report to reveal the relationships among AP1B, cellular polarity and intestinal tumorigenesis, and achieving a detailed understanding of AP1B will hopefully lead to discovery of therapeutic targets and novel biomarkers for intestinal cancer.

KW - AP1B

KW - APC

KW - intestine

KW - polarity

KW - tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=84155168013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84155168013&partnerID=8YFLogxK

U2 - 10.1002/ijc.26131

DO - 10.1002/ijc.26131

M3 - Article

VL - 130

SP - 1011

EP - 1020

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 5

ER -